Professor Gal Markel MD, PhD, MBA, is a renowned figure in the field of oncology within Israel and globally. Known for his profound expertise and pioneering work in the treatment of skin malignancies, he leads an extensive career in clinical patient care, academic research, and innovative cancer treatment development.

As the Director of the Medical Centre at Raben, and with his holistic approach to medicine, Professor Markel has significantly impacted the oncology sector. His distinct clinical treatment methods often combine traditional care with modern research that he continuously conducts. His work is not limited to patient care; he also actively involves in the development of original and innovative therapies in the field.

Throughout his career, Professor Markel has accumulated extensive knowledge and experience in cancer treatments. This comprehensive expertise has allowed him to become a forefront in innovating new treatment methods, rooted in deep understanding of cancer biology and its mechanism. He has led numerous research initiatives and developments, comprehensively contributing to the structure of cancer biology and the evolution of new treatment pathways.

An integral part of his roles, apart from his passion to constant research and development, lies in staying updated with world-class advancements in his field. He constantly keeps himself abreast in new international medical trends and findings in oncology, ensuring that he incorporates global scientific knowledge into his work.

Besides his impeccable work in patient care and research, Professor Markel is also a prominent figure among different companies and organisations. His consultancies encompass medical advices that are valuable in various sectors of health and medical industry. Notably, he plays a significant part in the field of immunooncology, which is evident through his various publications. Acknowledging his extensive contributions in the field of oncology, it can indeed be inferred that Professor Gal Markel stands as an individual of knowledge, experience and influence in the cancer research community globally. His rigorous work is a testament to his dedication and commitment to continually push boundaries in search of new treatment methods and solutions for cancer patients.

---